NetworkNewsBreaks

ThursdayJul 14, 2022 1:06 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awarded Patent in Japan, Submits Briefing Book

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, announced that it has been notified that it will be awarded a new patent in Japan, which makes the 26th world patent for the company. The patent, which is the third one granted in Japan, recognizes the company’s patented drug-delivery technology, DehydraTECH(TM), and its ability to deliver active pharmaceutical ingredients (“APIs”) more efficiently, regardless of the “food effect,” or the presence of food in the gastrointestinal system. Drug delivery is a key component of reliable drug dosing. According to the announcement, this is the first patent issued from Lexaria’s seventh…

Continue Reading

ThursdayJul 14, 2022 12:19 pm

NetworkNewsBreaks – Lehua Brands, CA State Fair Cannabis Awards to Offer Adult Fairgoers Opportunity to Experience Special Edition TerpTonic Beverages

Lehua Brands is serving as the official beverage of the CA State Fair Cannabis Awards and today announced the special edition TerpTonic beverages in collaboration with four of California’s most acclaimed cannabis cultivators. According to the announcement, the special edition TerpTonic beverages and slushies will be available for purchase (quantities may be limited) at the Lehua Brands booth (#13) within the CA Cannabis Exhibit at the CA State Fair in Expo Center Building One. The cultivators and their award-winning strains include two Golden Bear “Best of California” winners, Esensia Gardens (Buddha’s Hand) and Greenshock Farms (Passion Orange Guava), as well as two Gold Medal winners, Booney Acres (Gelonade) and Emerald Spirit Botanicals (Pink…

Continue Reading

ThursdayJul 14, 2022 11:21 am

NetworkNewsBreaks – Odyssey Health Inc.’s (ODYY) Spokesperson Brett Favre to Be Featured on RedChip Money Report(R)

Odyssey Health (OTC: ODYY), f/k/a Odyssey Group International Inc., will be featured in a new interview aired by RedChip Companies on The RedChip Money Report(R) on Bloomberg TV at 7 p.m. Eastern Time this Saturday, July 16. Bloomberg TV is available in an estimated 73 million homes across the U.S. In the exclusive interview, Odyssey Health’s spokesperson and Pro Football Hall of Fame quarterback Brett Favre discusses the major concussion he sustained in the final play of his professional career. Favre will share why he is proudly working to reduce and prevent concussions, the potential of Odyssey’s concussion treatment, and…

Continue Reading

ThursdayJul 14, 2022 11:13 am

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Completion of Partial Interest in Alberta-Based RNG Facility

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has completed the acquisition of a 67% interest in Grow the Energy Circle Ltd. (GrowTEC), a multi-faceted bioenergy venture of sustainable agriculture located in Alberta. Located on the Perry Family farm, GrowTEC integrates responsible best practices and renewable energy. The operating farm-scale biogas facility features an anaerobic digester that converts biodegradable waste into biogas, generating renewable power. With the acquisition now complete, EverGen plans on working with GrowTEC to add on and upgrade the facility; currently the project has an agreement with FortisBC to contribute to its target to…

Continue Reading

ThursdayJul 14, 2022 11:02 am

NetworkNewsBreaks – HIVE Blockchain Technologies Ltd. (TSX.V: HIVE) (NASDAQ: HIVE) (FSE: HBF) Releases Update Regarding Delayed Annual Filings

HIVE Blockchain Technologies (TSX.V: HIVE) (NASDAQ: HIVE) (FSE: HBF) is sharing an update regarding the status of its audited financial statements for the year ended March 31, 2022, as well as its CEO and CFO certifications, and management discussion and analysis for the same period. HIVE reports that the company is working diligently with its auditors to complete the required filings and plans on filing the documents on or before July 18, 2022. According to the update, HIVE notes that there has been “no material change in the information contained in the default announcement issued on June 29, 2022, and there is…

Continue Reading

WednesdayJul 13, 2022 4:10 pm

NetworkNewsBreaks – QSAM Biosciences Inc. (QSAM) Expands IP Estate with Receipt of Third US Patent for CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing next-generation targeted therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (“CycloSam(R)”), for the treatment of cancer and related diseases. The company today announced that the United States Patent & Trademark Office has granted a key patent protecting how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and provides for high purity in an efficient, facile and reproducible process at lower costs. “This patent issuance marks our third granted patent in the United States and further strengthens our IP estate, consisting of 14…

Continue Reading

WednesdayJul 13, 2022 2:58 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Featured in Stock2Me Podcast Spotlighting Two-Time Olympic Gold Medalist Abby Wambach

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products, is featured in the latest episode of InvestorBrandNetwork’s Stock2Me podcast. Hosted by Stuart Smith, the podcast talks with soccer play Abby Wambach, an Olympic gold medalist and member of ODYY’s sports advisory board. During the interview, Wambach discusses her soccer career and why she was drawn to Odyssey, a medical technology company that is developing a drug/device combination intended to treat concussion. Wambach and other members of the sports advisory board support the company’s efforts to enhance public awareness of traumatic brain…

Continue Reading

WednesdayJul 13, 2022 2:49 pm

NetworkNewsBreaks – American Rebel Holdings Inc. (NASDAQ: AREB) Closes $13M Private Placement

American Rebel (NASDAQ: AREB, AREBW), a designer and marketer of branded safes and personal security and self-defense products, has announced the closing of its private placement of common stock (or pre-funded warrants in lieu thereof) and warrants. Under the agreement, the company sold 11,711,712 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase 23,423,424 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold together with accompanying warrants at a combined purchase price of $1.11. The warrants will be immediately exercisable from the date of issuance at an…

Continue Reading

WednesdayJul 13, 2022 2:45 pm

NetworkNewsBreaks – Bit Digital Inc. (NASDAQ: BTBT) Issues June 2022 Production Update

Bit Digital (NASDAQ: BTBT), a digital asset mining company headquartered in New York, has announced its unaudited bitcoin and ethereum production and corporate updates for the month of June 2022. According to the announcement, the company earned 67.6 bitcoins and 0.0 ETHs in June 2022. In addition, on June 30, 2022, Treasury holdings of BTC and ETH were 860.7 and 313.6, with a fair market value of approximately $17.0 million and $0.3 million, respectively. As of June 30, 2022, the company owned 38,135 bitcoin miners and 731 ethereum miners with an estimated maximum total hash rate of 2.7 EH/s and…

Continue Reading

WednesdayJul 13, 2022 2:39 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Nearing Start Date for Its Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the pending start of its upcoming human nicotine study NIC-H22-1. Through the study, Lexaria expects to evidence that processing purified nicotine with its patented drug delivery technology, DehydraTECH(TM), leads to enhanced oral-tissue absorption and reduced negative experiences. NIC-H22-1, a minimum 36-person human pharmacokinetic (“PK”) randomized, double blinded, cross-over study, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the U.S. such as ON! and Zyn. The primary objective of the study is data collection from blood samples that will evidence…

Continue Reading